Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
Medicure Inc. stock logo
MPH
Medicure
C$1.25
-1.6%
C$1.04
C$0.63
C$1.27
C$13.05M0.94,035 shs1,500 shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.27
-11.5%
C$0.20
C$0.04
C$0.36
C$40.91M0.32198,342 shs407,425 shs
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$0.26
-1.9%
C$0.07
C$0.01
C$0.15
C$37.66M1.13626,457 shs76,000 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
Medicure Inc. stock logo
MPH
Medicure
0.00%0.00%+25.00%+83.82%+6.84%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-11.48%-20.59%+50.00%+45.95%+350.00%
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
-13.33%-3.70%+766.67%+2,500.00%+126.09%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
0.00
N/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00
N/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
Medicure Inc. stock logo
MPH
Medicure
C$21.08M0.62C$0.50 per share2.49C$1.91 per share0.65
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.01 per share35.00C$0.01 per shareN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$2.94M12.79C$0.31 per share0.83C$0.00 per share188.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
Medicure Inc. stock logo
MPH
Medicure
-C$2.03M-C$0.19N/AN/A-9.65%-10.18%-5.63%N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.66M-C$0.01N/AN/AN/A-117.77%-30.77%N/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
-C$7.92M-C$0.05N/AN/A-268.91%-602.73%-74.79%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/A2.24%N/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/A7.35%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
Medicure Inc. stock logo
MPH
Medicure
4.65
2.03
1.29
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
4.23
0.10
0.84
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
902.05
0.80
19.71

Institutional Ownership

CompanyInstitutional Ownership
HEXO Corp. stock logo
HEXO
HEXO
7.78%
Medicure Inc. stock logo
MPH
Medicure
23.10%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.10%

Insider Ownership

CompanyInsider Ownership
HEXO Corp. stock logo
HEXO
HEXO
4.69%
Medicure Inc. stock logo
MPH
Medicure
26.68%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.24%
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
24.34%
CompanyEmployeesShares OutstandingFree FloatOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.44 millionN/ANot Optionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A151.52 millionN/ANot Optionable
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
19144.85 millionN/ANot Optionable

Recent News About These Companies

Willow Biosciences to sell operating subsidiary for $3.38M
WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY
Willow Biosciences is looking for a buyer
WLLW:CA Willow Biosciences Inc.
Willow Biosciences Inc.
Closing Bell: Willow Biosciencesinc flat on Monday (WLLW)
TSX:WLLW (Willow Biosciences Inc.)
Willow Biosciences Inc (WLLW)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HEXO stock logo

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Medicure stock logo

Medicure CVE:MPH

C$1.25 -0.02 (-1.57%)
As of 06/27/2025

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Voyageur Pharmaceuticals stock logo

Voyageur Pharmaceuticals CVE:VM

C$0.27 -0.04 (-11.48%)
As of 07/4/2025 03:59 PM Eastern

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Willow Biosciences stock logo

Willow Biosciences TSE:WLLW

C$0.26 -0.01 (-1.89%)
As of 07/3/2025

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.